Appropriate use criteria of left atrial appendage closure devices: latest evidences.


Journal

Expert review of medical devices
ISSN: 1745-2422
Titre abrégé: Expert Rev Med Devices
Pays: England
ID NLM: 101230445

Informations de publication

Date de publication:
Jun 2023
Historique:
medline: 30 5 2023
pubmed: 2 5 2023
entrez: 2 5 2023
Statut: ppublish

Résumé

Atrial fibrillation is the most common arrythmia and it is linked to an increased risk of stroke. Even if anticoagulation therapy reduces the rate of stroke the benefits of this therapy have to be balanced with the increased risk of hemorrhagic event. Left atrial appendage closure is a valid alternative to long-term anticoagulation in patients with atrial fibrillation and high hemorrhagic risk. Actually new devices with different features have been tested and introduced progressively in the clinical practice. Improvements in preprocedural imaging evaluation and the learning curve of the operators led to percutaneous left atrial appendage closure a safe and effective procedure. A good knowledge of different devices and the technique of implant is necessary for optimization percutaneous left atrial appendage closure and the reduction of complications during the acute phase and follow up.

Identifiants

pubmed: 37128658
doi: 10.1080/17434440.2023.2208748
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-503

Auteurs

Fabrizio Guarracini (F)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Eleonora Bonvicini (E)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Alberto Preda (A)

Cardiothoracovascular Department, Electrophysiology Unit, Niguarda Hospital, Milano, Italy.

Marta Martin (M)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Simone Muraglia (S)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Giulia Casagranda (G)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Marianna Mochen (M)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Alessio Coser (A)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Silvia Quintarelli (S)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Stefano Branzoli (S)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Roberto Bonmassari (R)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Massimiliano Marini (M)

Department of Cardiology, S. Chiara Hospital, Trento, Italy.

Patrizio Mazzone (P)

Cardiothoracovascular Department, Electrophysiology Unit, Niguarda Hospital, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH